![Shu Feng Zhang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Shu Feng Zhang
Chairman at Beijing Biostar Pharmaceuticals Co. Ltd.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Li Tang | M | 61 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 22 years |
Kai Lin Liu | M | 41 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 4 years |
Quan Zhou | F | 38 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 15 years |
Heng Xie | M | 65 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 2 years |
Rong Guo Qiu | M | 62 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 22 years |
Dong Ran | M | 38 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 1 years |
Ri Xiang Kong | M | 47 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 21 years |
Song Dong Meng | M | 54 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 2 years |
Xing Xiao | M | 53 |
Tsinghua University
| 28 years |
Cheng Zhang | M | 49 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 6 years |
Li Xin Wang | M | 54 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 3 years |
Luo Ken Yi | M | 66 |
Tsinghua University
| 25 years |
Pai Zhu | M | 31 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 3 years |
Jian Yun Chai | M | 63 |
Tsinghua University
| 25 years |
Hong Yin | M | 62 |
Tsinghua University
| 25 years |
Pei Qing Ye | M | 61 |
Tsinghua University
| 27 years |
Yik Pun Chan | M | 42 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | - |
Cheng Zhang | M | 70 |
Tsinghua University
| 25 years |
Rong Qing Zhang | M | 67 |
Tsinghua University
| 26 years |
Xiao Chen | M | 61 |
Tsinghua University
| 27 years |
Wu Chao Chen | M | 54 |
Tsinghua University
| 26 years |
Fei Peng | M | 50 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Zhen Zhang | M | 47 |
Tsinghua University
| 9 years |
Hong Bin Sun | M | 55 |
Tsinghua University
| 10 years |
Cen Shi | M | 48 |
Tsinghua University
| 7 years |
Shao Ping Ma | M | 63 |
Tsinghua University
| 19 years |
Yu Di Gao | M | 47 |
Tsinghua University
| 9 years |
Ling Qin | F | 52 |
Tsinghua University
| 6 years |
Jiang Tao Yu | M | 49 |
Tsinghua University
| 6 years |
Peng Yu | M | 48 |
Tsinghua University
| 6 years |
Yan Fang Xu | M | 56 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | - |
Hai Tao Cui | M | 49 |
Tsinghua University
| 6 years |
Jin Fei Zhang | M | 51 |
Tsinghua University
| 6 years |
Yang Qing Huang | M | 50 |
Tsinghua University
| 6 years |
Mei Xie | F | 47 |
Tsinghua University
| 6 years |
Xiao Dan Jiang | M | 51 |
Tsinghua University
| 7 years |
Kai Xin Xu | M | 51 |
Tsinghua University
| 6 years |
Yaxiao Liu | M | 50 |
Tsinghua University
| 6 years |
Bin Zhang | M | 42 |
Tsinghua University
| 7 years |
Peng Cheng Ji | M | 43 |
Tsinghua University
| 10 years |
Chao Shen | M | 43 |
Tsinghua University
| 6 years |
Sheng Lin | M | 50 |
Tsinghua University
| 6 years |
Guo Tao Lu | M | - |
Tsinghua University
| 5 years |
Xiao Bo Ge | M | 53 |
Tsinghua University
| 7 years |
Lei Shi | M | 50 |
Tsinghua University
| 6 years |
Cheng Shao | M | - |
Tsinghua University
| 7 years |
Cheng Yan | M | 49 |
Tsinghua University
| 8 years |
Qing Li | M | 49 |
Tsinghua University
| 6 years |
Gangjiang Li | M | 48 |
Tsinghua University
| 6 years |
Jian Xue | M | 48 |
Tsinghua University
| 6 years |
Carrie Liqun Liu | F | 42 |
Tsinghua University
| 7 years |
Yong Sheng Ma | M | 59 |
Tsinghua University
| 11 years |
Tao Zhang | M | 55 |
Tsinghua University
| 1 years |
Xin Zhou Wu | M | 48 |
Tsinghua University
| 4 years |
Xiaohua Wei | F | 55 |
Tsinghua University
| 2 years |
Peng Dai | M | 44 |
Tsinghua University
| 4 years |
Yu Gao Xu | M | 55 |
Tsinghua University
| 3 years |
Yu Shi Shen | M | 46 |
Tsinghua University
| 4 years |
Lin Ding | M | 50 |
Tsinghua University
| 3 years |
Jin Li | M | 51 |
Tsinghua University
| 4 years |
Tian Yi Wang | M | 61 |
Tsinghua University
| 4 years |
Bi Chen | M | 63 |
Tsinghua University
| 2 years |
Bing Yu | M | 44 |
Tsinghua University
| 4 years |
Ji Wu | M | 51 |
Tsinghua University
| 3 years |
Hu Xie | M | 50 |
Tsinghua University
| 4 years |
Fu Min Zhou | M | 54 |
Tsinghua University
| 3 years |
Jian Zhao | M | 49 |
Tsinghua University
| 4 years |
Guang Yu He | M | 52 |
Tsinghua University
| 3 years |
Hua Zhong Yang | M | 57 |
Tsinghua University
| 3 years |
Tian Lei | M | 59 |
Tsinghua University
| 2 years |
Zhiqiang He | M | 41 |
Tsinghua University
| 4 years |
Xi Yue Liu | M | 51 |
Tsinghua University
| 2 years |
Dan Liu | M | 54 |
Tsinghua University
| 3 years |
Wei Cao | M | 45 |
Tsinghua University
| 4 years |
Si Shen | F | 42 |
Tsinghua University
| 4 years |
Shuang Xue | M | 53 |
Tsinghua University
| 4 years |
Ya Hui Zhou | M | 47 |
Tsinghua University
| 4 years |
Xian Liang Wang | M | 48 |
Tsinghua University
| 7 years |
Li Yun Ru | M | 45 |
Tsinghua University
| 4 years |
Wen Cheng Xue | M | 52 |
Tsinghua University
| 3 years |
Hui Wen Wang | M | 45 |
Tsinghua University
| 4 years |
Tao Lian | M | 47 |
Tsinghua University
| 4 years |
Li Hui Ou Yang | F | 53 |
Tsinghua University
| 2 years |
Zhenyu Li | M | 50 |
Tsinghua University
| 3 years |
Jin Huan Xu | M | 52 |
Tsinghua University
| 2 years |
Yan Su | M | 52 |
Tsinghua University
| 2 years |
Jiang Chun Luo | M | - |
Tsinghua University
| 4 years |
Hai Xin Duan | M | 52 |
Tsinghua University
| 3 years |
Jun Li | M | 45 |
Tsinghua University
| 4 years |
Sheng Li Zhao | M | 54 |
Tsinghua University
| 2 years |
Ren Dong Wu | M | 52 |
Tsinghua University
| 3 years |
Chao Huang | M | 52 |
Tsinghua University
| 4 years |
Shi Jie Zu | M | 56 |
Tsinghua University
| 3 years |
Sheng Wu Wu | M | 51 |
Tsinghua University
| 1 years |
Wei Bai | M | 46 |
Tsinghua University
| 1 years |
Ming Sun | M | 48 |
Tsinghua University
| 4 years |
Qun Hui Sun | M | 45 |
Tsinghua University
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
China | 97 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Shu Feng Zhang
- Personal Network